The Long-Term Cardiovascular Effects of Metformin on Patients with Newly Diagnosed Type 2 Diabetes

被引：0
|
作者：
Yue, Tong
Wang, Xulin
Zhao, Minzhe
Weng, Jianping
Luo, Sihui
Zheng, Xueying
机构：
来源：
DIABETES | 2023年 / 72卷
关键词：
D O I：
10.2337/db23-1362-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1362-P
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Database Evaluation of the Effects of Long-Term Rosiglitazone Treatment on Cardiovascular Outcomes in Patients With Type 2 Diabetes
    Loebstein, Ronen
    Dushinat, Marina
    Vesterman-Landes, Janet
    Silverman, Barbara
    Friedman, Nurit
    Katzir, Itzhak
    Kurnik, Daniel
    Lomnicky, Yossef
    Kokia, Ehud
    Halkin, Hillel
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (02): : 173 - 180
  • [22] Long-term effects of intensive multifactorial treatment on total and cardiovascular mortality in patients with type 2 diabetes
    Gzede, P.
    Parving, H.-H.
    Pedersen, O.
    DIABETOLOGIA, 2007, 50 : S48 - S48
  • [23] Effect of Hypoglycemia during Intensive Insulin Therapy on Long-Term Glycemic Control in Patients with Newly Diagnosed Type 2 Diabetes
    Xu, Lijuan
    Li, Yanbing
    DIABETES, 2018, 67
  • [24] Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial
    de Jager, J.
    Kooy, A.
    Schalkwijk, C.
    van der Kolk, J.
    Lehert, P.
    Bets, D.
    Wulffele, M. G.
    Donker, A. J.
    Stehouwer, C. D. A.
    JOURNAL OF INTERNAL MEDICINE, 2014, 275 (01) : 59 - 70
  • [25] Long-term effects on glycaemic control and β-cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial
    Chon, Suk
    Rhee, Sang Youl
    Ahn, Kyu Jeung
    Baik, Sei Hyun
    Park, Yongsoo
    Nam, Moon Suk
    Lee, Kwan Woo
    Yoo, Soon Jib
    Koh, Gwanpyo
    Lee, Dae Ho
    Kim, Young Seol
    Woo, Jeong-Taek
    DIABETES OBESITY & METABOLISM, 2018, 20 (05): : 1121 - 1130
  • [26] Comparison of Effects of Gliclazide, Metformin and Pioglitazone Monotherapies on Glycemic Control and Cardiovascular Risk Factors in Patients with Newly Diagnosed Uncontrolled Type 2 Diabetes Mellitus
    Erem, C.
    Ozbas, H. M.
    Nuhoglu, I.
    Deger, O.
    Civan, N.
    Ersoz, H. O.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (05) : 295 - 302
  • [27] The role of clinical response to metformin in patients newly diagnosed with type 2 diabetes: a monotherapy study
    Mahrooz, Abdolkarim
    Parsanasab, Hassan
    Hashemi-Soteh, Mohammad Bagher
    Kashi, Zahra
    Bahar, Adele
    Alizadeh, Ahad
    Mozayeni, Maliheh
    CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 15 (02) : 159 - 165
  • [28] Short Course of Insulin Treatment versus Metformin in Newly Diagnosed Patients with Type 2 Diabetes
    Seghieri, Marta
    Rebelos, Eleni
    Mari, Andrea
    Sciangula, Luigi
    Giorda, Carlo
    Ferrannini, Ele
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (09):
  • [29] The role of clinical response to metformin in patients newly diagnosed with type 2 diabetes: a monotherapy study
    Abdolkarim Mahrooz
    Hassan Parsanasab
    Mohammad Bagher Hashemi-Soteh
    Zahra Kashi
    Adele Bahar
    Ahad Alizadeh
    Maliheh Mozayeni
    Clinical and Experimental Medicine, 2015, 15 : 159 - 165
  • [30] Metformin affects DNA methylation patterns in newly-diagnosed patients with type 2 diabetes
    Garcia-Calzon, S.
    Schrader, S.
    Perfilyev, A.
    Ling, C.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S183 - S183
12345